PHARMSOL NEWS ISSUE NO. 3

31 January, 2023 12:00 am

Three-Dimensional Printing (3DP): An Innovative and Promising Technology in Pharmaceutical Industry

31 July, 2022 12:00 am

Container Closure System Selection Criteria: Critical Quality Attribute For Non-Sterile Drug Products

18 May, 2016 12:00 am

We are delighted to announce the opening of our new office located at Zhuhai, China

15 January, 2017 12:00 am

EU GMP Certification of Galpha Baddi supported by PharmSol Group

18 April, 2019 12:00 am

We are delighted to announce the opening of our new office located at Nanjing, China

31 October, 2022 12:00 am

Needle Free Injection Technology (NFIT) in Pharmaceutical Drug Delivery

30 November, 2021 12:00 am

Orodispersible Films – Emerging and Patient Centric Drug Delivery System

30 September, 2021 12:00 am

Dry Powder Inhalers – A preferred form of inhalation therapeutic segment for respiratory diseases

30 January, 2022 12:00 am

Formulation Development using Soft Gelatin-Based Technology

30 March, 2022 12:00 am

Transdermal Drug Delivery System (TDDS)

31 July, 2022 12:00 am

Container Closure System Selection Criteria: Critical Quality Attribute For Non-Sterile Drug Products

3 August, 2022 12:00 am

EU GMP Success of Evertogen Life Sciences Limited with the support of PharmSol

20 July, 2022 12:00 am

EU GMP Success of Unison Pharmaceuticals Pvt. Ltd. with the support of PharmSol

24 June, 2022 12:00 am

EU GMP Success of Sri Krishna Pharmaceuticals Limited – OSD (Tablets, Capsules) Facility with the support of PharmSol

24 June, 2022 12:00 am

Successful EU GMP Certification of Sri Krishna Pharmaceuticals Limited – Warehouse Facility with the support of PharmSol

31 May, 2022 12:00 am

Successful EU GMP Certification of Shandong Xinhua Pharmaceutical Co. Ltd supported by Team PharmSol

30 May, 2022 12:00 am

Effervescent Tablets; Practical and Convenient Delivery System For Drug Administration

30 July, 2021 12:00 am

MUPS – A Promising & Flexible Controlled Drug Delivery System

30 May, 2021 12:00 am

Excipients: From an auxiliary substance to game changer in Drug Delivery

30 December, 2020 12:00 am

Hot Melt Technology – Novel Solvent Free Approach

25 November, 2020 12:00 am

EU Regulatory requirement on Falsified Medicine Directive (FMD)

20 August, 2020 12:00 am

Successful EU GMP Certification of Eskayef Pharmaceuticals Limited – Rupganj Plant (Sterile) supported by Team PharmSol

21 July, 2020 12:00 am

Navigating Regulatory Requirements for Drug Substances

7 July, 2020 12:00 am

Drug Substances – Managing Risks

14 June, 2020 12:00 am

The Future of Pharmaceutical Contract Development

24 July, 2020 12:00 am

Successful EU GMP Certification of Eskayef Pharmaceuticals Limited – Rupganj Plant (OSD) supported by Team PharmSol

11 May, 2020 12:00 am

Challenges in the EUGMP Inspection of Sterile Facility

23 April, 2020 12:00 am

Realignment in Drug Substances – POST COVID 19

8 April, 2020 12:00 am

A Perspective on Changing Regulatory Landscape in China Pharma Industry

13 February, 2020 12:00 am

PharmSol Team Message

3 October, 2019 12:00 am

EU GMP Certification of Jiangsu Hansoh Pharmaceutical Co. Ltd. supported by PharmSol Group

15 June, 2019 12:00 am

EU GMP Certification of Shouguang Fukang Pharmaceutical Ltd. supported by PharmSol Group

20 August, 2019 12:00 am

EU GMP Certification of Beximco Pharmaceuticals Ltd. supported by PharmSol Group

14 August, 2019 12:00 am

EU GMP CERTIFICATION OF SRI KRISHNA PHARMACEUTICALS LTD. (SKPL) SUPPORTED BY PHARMSOL GROUP

18 April, 2019 12:00 am

EU GMP CERTIFICATION OF UNISON PHARMACEUTICAL PVT LTD SUPPORTED BY PHARMSOL GROUP

28 October, 2019 12:30 am

PHARMSOL NEWS ISSUE NO. 5

14 October, 2019 12:15 am

PHARMSOL NEWS ISSUE NO. 4

3 October, 2019 12:00 am

EU GMP Success of Jiangsu Hansoh Pharmaceutical Group Co. Ltd. – Injectable Facility with the support of PharmSol

20 August, 2019 12:00 am

EU GMP Success of Beximco Pharmaceuticals Ltd. with the support of PharmSol

7 November, 2016 12:00 am

Sinopharm Zhijun & PharmSol – Strategic Cooperation Agreement for Co-development of Products

1 February, 2018 8:00 am

PharmSol News Issue No. 1

1 March, 2018 12:00 am

PharmSol News Issue No. 2

16 November, 2016 12:00 am

PharmSol’s Presence at CEIV Pharma Audit, Hong Kong

22 January, 2017 12:00 am

Strategic Cooperation – Jiangsu Hansoh and PharmSol Group

12 October, 2016 12:00 am

DNATA, Dubai, CEIV Pharma Audit by PharmSol

26 June, 2016 12:00 am

PharmSol conducts CEIV Pharma Audit at Changi Airport (SIN)

15 June, 2019 12:00 am

EU GMP Success of Shouguang Fukang Pharmaceutical Co., Ltd. – OSD (Tablets, Capsules) with the support of PharmSol

18 August, 2016 12:00 am

Training Program at Medicines Authority, Malta

15 March, 2016 12:00 am

Successful CEIV Pharma Training

13 April, 2018 12:00 am

EU GMP Success of Akriti Pharmaceuticals Pvt. Ltd. – OSD (Tablets) facilitywith the support of PharmSol

23 October, 2017 12:00 am

Successful EU GMP Certification of Shouguang Fukang Pharmaceutical Co. Ltd. (OSD (Tablets) Facility) supported by Team PharmSol

19 January, 2017 12:00 am

Changzhou Yabang and PharmSol Group Strategic Alliance

Our Establishments

PharmSol GmbH

Bad Oldesloe, Germany

PharmSol Europe Limited

Mosta, Malta

Pharmaceutical Solutions FZCO

Jebel Ali, Dubai, United Arab Emirates

Pharmaceutical Solutions DMCC

Jumeirah Lake Towers, Dubai

PharmSol Egypt

Heliopolis, Cairo, Egypt

PharmSol India Pvt. Ltd.

Hyderabad, India

PharmSol (Nanjing) Pharmaceutical Technology Co.Ltd

Nanjing City, Jiangsu Province, PR China

PharmSol APAC Limited

Hong Kong, China

PharmSol-Pharmaceutical Products Trading

Makati City, Philippines

PharmSol Europe Limited (Rep. Office)

Ho Chi Minh City, Vietnam